Punt CJ - Search Results

1

A randomised phase III study on capecitabine, oxaliplatin and bevacizumab with or without cetuximab in first-line advanced colorectal cancer, the CAIRO2 study of the Dutch Colorectal Cancer Group (DCCG). An interim analysis of toxicity.

Tol J, Koopman M, Rodenburg CJ, Cats A, Creemers GJ, Schrama JG, Erdkamp FL, Vos AH, Mol L, Antonini NF, Punt CJ. Tol J, et al. Among authors: punt cj. Ann Oncol. 2008 Apr;19(4):734-8. doi: 10.1093/annonc/mdm607. Epub 2008 Feb 13. Ann Oncol. 2008. PMID: 18272912 Free article. Clinical Trial.

2

Fluorouracil continuous infusion plus alfa interferon plus oral folinic acid in advanced colorectal cancer.

Punt CJ, de Mulder PH, Burghouts JT, Wagener DJ. Punt CJ, et al. Semin Oncol. 1992 Apr;19(2 Suppl 3):208-10. Semin Oncol. 1992. PMID: 1557649 Clinical Trial.

3

Current status and future directions in the perioperative treatment of pancreatic cancer.

Wagener DJ, Punt CJ, Wilke H. Wagener DJ, et al. Among authors: punt cj. Ann Oncol. 1994;5 Suppl 3:87-90. doi: 10.1093/annonc/5.suppl_3.s87. Ann Oncol. 1994. PMID: 8204535 Review.

4

Continuous infusion of high-dose 5-fluorouracil in combination with leucovorin and recombinant interferon-alpha-2b in patients with advanced colorectal cancer. A Multicenter Phase II study.

Punt CJ, Burghouts JT, Croles JJ, van Liessum PA, de Mulder PH, Kamm Y. Punt CJ, et al. Cancer. 1993 Oct 1;72(7):2107-11. doi: 10.1002/1097-0142(19931001)72:7<2107::aid-cncr2820720708>3.0.co;2-m. Cancer. 1993. PMID: 8374869 Clinical Trial.

5

Tallimustine in advanced previously untreated colorectal cancer, a phase II study.

Punt CJ, Humblet Y, Roca E, Dirix LY, Wainstein R, Polli A, Corradino I. Punt CJ, et al. Br J Cancer. 1996 Mar;73(6):803-4. doi: 10.1038/bjc.1996.140. Br J Cancer. 1996. PMID: 8611384 Free PMC article. Clinical Trial.

6

Advanced colorectal cancer, refractory to infusional fluorouracil treatment: efficacy of second line fluorouracil in combination with a different biochemical modulation.

van Halteren HK, Wagener DJ, Vreugdenhil G, Punt CJ. van Halteren HK, et al. Among authors: punt cj. Anticancer Res. 1997 Jul-Aug;17(4A):2715-9. Anticancer Res. 1997. PMID: 9252703

7

Phase IB study of doxorubicin in combination with the multidrug resistance reversing agent S9788 in advanced colorectal and renal cell cancer.

Punt CJ, Voest EE, Tueni E, Van Oosterom AT, Backx A, De Mulder PH, Hecquet B, Lucas C, Gerard B, Bleiberg H. Punt CJ, et al. Br J Cancer. 1997;76(10):1376-81. doi: 10.1038/bjc.1997.563. Br J Cancer. 1997. PMID: 9374386 Free PMC article. Clinical Trial.

8

New drugs in the treatment of colorectal carcinoma.

Punt CJ. Punt CJ. Cancer. 1998 Aug 15;83(4):679-89. doi: 10.1002/(sici)1097-0142(19980815)83:4<679::aid-cncr8>3.0.co;2-f. Cancer. 1998. PMID: 9708931 Review.

9

Phase I and pharmacokinetic study of E7070, a novel sulfonamide, given at a daily times five schedule in patients with solid tumors. A study by the EORTC-early clinical studies group (ECSG).

Punt CJ, Fumoleau P, van de Walle B, Faber MN, Ravic M, Campone M. Punt CJ, et al. Ann Oncol. 2001 Sep;12(9):1289-93. doi: 10.1023/a:1012287111922. Ann Oncol. 2001. PMID: 11697842 Free article. Clinical Trial.

10

Adjuvant interferon-alpha for melanoma revisited: news from old and new studies.

Punt CJ, Eggermont AM. Punt CJ, et al. Ann Oncol. 2001 Dec;12(12):1663-6. doi: 10.1023/a:1013592219007. Ann Oncol. 2001. PMID: 11843241 Free article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

496 results

Search Page

Filters